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Abstract
Purpose We tested the vagal withdrawal concept for heart rate (HR) and cardiac output (CO) kinetics upon moderate exercise 
onset, by analysing the effects of vagal blockade on cardiovascular kinetics in humans. We hypothesized that, under atropine, 
the φ1 amplitude (A1) for HR would reduce to nil, whereas the A1 for CO would still be positive, due to the sudden increase 
in stroke volume (SV) at exercise onset.
Methods On nine young non-smoking men, during 0–80 W exercise transients of 5-min duration on the cycle ergometer, 
preceded by 5-min rest, we continuously recorded HR, CO, SV and oxygen uptake ( V̇O2) upright and supine, in control 
condition and after full vagal blockade with atropine. Kinetics were analysed with the double exponential model, wherein 
we computed the amplitudes (A) and time constants (τ) of phase 1 (φ1) and phase 2 (φ2).
Results In atropine versus control, A1 for HR was strongly reduced and fell to 0 bpm in seven out of nine subjects for HR 
was practically suppressed by atropine in them. The A1 for CO was lower in atropine, but not reduced to nil. Thus, SV only 
determined A1 for CO in atropine. A2 did not differ between control and atropine. No effect on τ1 and τ2 was found. These 
patterns were independent of posture.
Conclusion The results are fully compatible with the tested hypothesis. They provide the first direct demonstration that vagal 
blockade, while suppressing HR φ1, did not affect φ1 of CO.
Keywords Heart rate · Stroke volume · Cardiac output · Exercise transients · atropine
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pH  Negative logarithm of hydrogen ion 
concentration
SV  Stroke volume
V̇CO2  Carbon dioxide output
V̇O2  Oxygen uptake
φ1  First phase of the double exponential model
φ2  Second phase of the double exponential 
model
τ  Time constant
Introduction
The oxygen uptake ( V̇O2) kinetics at the onset of a moder-
ate-intensity exercise is characterised by two distinct phases 
(Whipp et al. 1982), which have been modelled as a sum of 
two exponentials (Barstow and Molé 1987). The first rapid 
phase (φ1) has been ascribed to a sudden increase in cardiac 
output (CO) and was called “cardiodynamic phase” (Was-
serman et al. 1974). The demonstration of a rapid increase 
in CO at exercise onset is the strongest piece of evidence 
supporting this interpretation (Cummin et al. 1986; Eriksen 
et al. 1990; De Cort et al. 1991; Yoshida et al. 1993). The 
second or primary phase (φ2), slower than φ1, was attributed 
to muscle metabolic adaptations (di Prampero 1981; Whipp 
and Ward 1990; Poole and Jones 2012; Ferretti 2015). Appli-
cation of the double exponential model to the analysis of the 
CO kinetics at exercise onset led to the demonstration that 
the φ1 for V̇O2 kinetics may be entirely explained by the φ1 
for CO (Faisal et al. 2009; Lador et al. 2006, 2008).
Two different mechanisms have been hypothesised to 
explain the φ1 for CO. On one side, some authors postu-
lated that a sudden fall in vagal activity occurs at exercise 
start, leading to a fast increase in heart rate (HR) and, thus, 
in CO (Fagraeus and Linnarsson 1976; Fontolliet et al. 2018; 
Lador et al. 2006, 2008): this is the so-called vagal with-
drawal concept, although even an incomplete withdrawal 
of vagal modulation of HR was recently considered suffi-
cient to explain the phenomenon (White and Raven 2014). 
On the other side, some authors postulated that at exercise 
start there is a rapid increase in venous return, due to sud-
den displacement of blood from the contracting muscles to 
the heart by muscle pump action. This would lead to an 
immediate increase in stroke volume (SV) and, thus, in CO 
(Laughlin 1987; Leyk et al. 1994; Linnarsson et al. 1996; 
Wieling et al. 1996; Sundblad et al. 2000; Schneider et al. 
2002; Stenger et al. 2012). Fagoni et al. (2020) argued that 
these two postulated mechanisms may coexist and are not 
mutually exclusive, one driven by HR, and the other by SV.
In the present study, the vagal withdrawal concept for 
CO kinetics, which thus far has only received indirect sup-
port, was tested. Fagraeus and Linnarsson (1976) demon-
strated the disappearance of φ1 for HR after complete vagal 
withdrawal with atropine without measuring CO. Lador 
et al. (2008) demonstrated that in acute hypoxia (i.e. a con-
dition characterised by lower vagal activity than normoxia) 
the amplitude of φ1 (A1) for HR and CO kinetics was lower 
than in normoxia. Moreover, a rapid initial component in 
HR on-kinetics was not found in heart transplant recipients 
(Grassi et al. 1997).
All this evidence was indirect. The vagal withdrawal 
concept for CO was not tested under vagal blockade so far. 
Vagal blockade inhibits the parasympathetic modulation 
of heart activity already at rest. Therefore, no vagal with-
drawal should occur at exercise onset under vagal block-
ade. If the hypothesis by Fagoni et al. (2020) is correct, we 
should expect that, under vagal blockade, the A1 for HR 
would reduce to nil, whereas the A1 for CO, though having 
a smaller size than in control condition, would still be visible 
and positive, due to the sudden increase in SV.
To test the vagal withdrawal concept, we aimed to deter-
mine the V̇O2, CO, and HR kinetics during vagal blockade 
with atropine, and to compare these responses with control 
conditions. We analysed the data using the double exponen-
tial model and we computed the characteristic parameters 




Nine healthy non-smoking men subjects took part in the 
study. They were (mean ± SD) 23 ± 3 years old, 180 ± 3 cm 
tall, and 77 ± 6 kg heavy.
Protocol
Subjects were asked to come to the laboratory on two sepa-
rate days, one for the protocol under vagal blockade and one 
for the control condition. During each testing session, the 
protocol was carried out in both upright and supine position, 
administered in a random order. Parasympathetic blockade 
was obtained by injecting a single dose of 0.04 mg/kg (mean 
3.06 ± 0.23 mg, range 2.7–3.4 mg) of atropine, using a short 
indwelling venous catheter in an antecubital vein (Yasue 
et al. 1986; Morikami et al. 1988; Goldberger et al. 2001; 
Ferretti et al. 2005; Fontolliet et al. 2018).
After participants' preparation and instrument calibration, 
3-min rest monitoring recordings were performed, during 
which blood sampling and CO determination with the acety-
lene method were done. Then, the subject was asked to per-
form three exercise transients from 0 to 80 W. The starting 
signal was provided by a verbal countdown. The flywheel 
was not pre-accelerated. The first bout lasted 6 to 7 min, to 
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allow blood sampling and CO determination with the acety-
lene method after 5 min of exercise (at exercise steady state), 
while the second and third bouts lasted 5 min, at the end of 
which only blood sampling was taken. Each exercise bout 
was followed by 6 min of recovery, during which  [La]b blood 
sampling was performed at minutes 1, 3, and 5.
Measurements
The time course of oxygen and carbon dioxide partial pres-
sures throughout the respiratory cycles were continuously 
monitored by a mass spectrometer (Balzers Prisma, Balz-
ers, Liechtenstein) calibrated against gas mixtures of known 
composition. The inspiratory and expiratory ventilation 
was measured by an ultrasonic flowmeter  (Spiroson®, ECO 
MEDICS AG, Duernten, Switzerland) calibrated with a 3 l 
syringe. HR was continuously measured by electrocardiog-
raphy (Elmed ETM 2000, Heiligenhaus, Germany). Con-
tinuous recordings of arterial pulse pressure were obtained 
at a fingertip of the left arm by means of a non-invasive cuff 
pressure recorder  (Portapres®,  Finapres® Medical Systems, 
Enschede, The Netherlands). Steady-state CO values were 
obtained by means of the open circuit acetylene method 
(Barker et al. 1999), with a procedure previously described 
(Lador et al. 2006), implying determination of partition 
coefficients for acetylene (Meyer and Scheid 1980). The 
rationale of this methodological approach was previously 
discussed (Lador et al. 2006, 2008).
All signals were digitalized in parallel by a 16-channel 
A/D converter (MP150 system with AcqKnowledge acquisi-
tion and analysis software,  BIOPAC® Systems Inc., Goleta, 
CA, USA) and stored on a computer. The acquisition rate 
was 400 Hz.
Blood lactate concentration  ([La]b) was measured by an 
electro enzymatic method (Eppendorf EBIO 6666, Erlangen, 
Germany) on 10 μL blood samples taken from the right ear-
lobe. Capillary blood gas composition and pH were meas-
ured by microelectrodes (Instrumentation Laboratory Syn-
thesis 10, Lexington, MA, USA) on 50 μL blood samples 
taken from the right earlobe.
Ergometers
In an upright position, subjects exercised on a standard 
electrically braked cycle ergometer (Ergo-metrics 800S, 
Ergo-line, Bitz, Germany). In the supine position, an electri-
cally braked arm-cycle ergometer (Ergoselect 400, Ergoline 
GmbH, Bitz, Germany), modified for leg pedalling in supine 
posture, was used. Subjects wore race cycling shoes, allow-
ing fixation of their feet to the pedals. The subjects were 
asked to keep a pedalling frequency between 60 and 80 rpm 
(visual feedback). The pedalling frequency was recorded, 
and its sudden increase at the exercise onset and decrease at 
the exercise offset were used as markers to precisely iden-
tify the start and the end of exercise. In both positions, the 
electro-mechanical characteristics of the ergometers were 
such as to permit workload application in less than 50 ms.
Data treatment
Oxygen and carbon dioxide partial pressures traces were 
aligned with the flowmeter traces and breath-by-breath V̇
O2 and carbon dioxide output ( V̇CO2) were then computed 
off-line by means of a modified version of Grønlund’s algo-
rithm (1984) run in  LabVIEW® environment  (LabVIEW® 
5.0, National Instruments™, Austin, TX, USA). The char-
acteristics and the physiological implications of Grønlund’s 
algorithm have been previously discussed elsewhere (Capelli 
et al. 2001, 2011; Lador et al. 2006).
Arterial blood pressure profiles were analysed to 
obtain beat-by-beat values using the  Beatscope® software 
 (Finapres® Medical Systems, Enschede, The Netherlands). 
The same software also provided SV by means of the Mod-
elflow method (Wesseling et al. 1993). Beat-by-beat CO was 
computed as the product of single-beat SV times the corre-
sponding single-beat HR. The data were then corrected for 
method’s inaccuracy, as previously described (Kenfack et al. 
2004; Tam et al. 2004; Lador et al. 2006). Individual correc-
tion factors were calculated at steady state, using the open-
circuit acetylene CO values as reference, and applied dur-
ing dynamic states with rapid changes in CO (van Lieshout 
et al. 2003). The calibration factors were the same at rest 
(1.02 ± 0.29) and exercise (1.03 ± 0.24, non-significant).
The three transitions of either V̇O2, CO or HR were time 
aligned, by setting the time of exercise start as time zero for 
the analysis of the on-kinetics. Then CO, HR and V̇O2 traces 
from the three repetitions were pooled together for each sub-
ject without interpolation (Bringard et al. 2014). For each 
variable, the time course upon exercise onset was analysed 
by the double exponential model (Barstow and Molé 1987; 
Lador et al. 2006):
where b, A, d, and τ are the baseline values at rest, the ampli-
tude, the time delay, and the time constant, respectively. The 
subscripts 1 and 2 refer to the φ1 and the φ2 of the on-kinet-
ics, respectively. ϴ is the Heaviside function (ϴ(t) = 0 if t < 0 
and ϴ(t) = 1 if t ≥ 0). When A1 = 0, the second term of the 
right-hand branch of Eq. (1) cancels out. In this case, (i) τ1 
becomes meaningless and cannot be computed so that for τ1 
“n” may be less than the number of subjects, and (ii) Eq. (1) 
reduces to a single exponential equation, with one time con-
stant, equal to τ2, and overall amplitude of response equal to 
A2. If the biexponential model provided A1 not significantly 
(1)
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different from zero, A1 was set as equal to 0 L  min−1, τ1 was 
neglected as meaningless, and a mono-exponential analysis 
of φ2 was applied.
The total sum of the squared 2 residuals (RESNORM 
variable) was also systematically calculated by MATLAB 
function. The comparison of the RESNORM between dou-
ble exponential and mono-exponential analysis was used as 
a quality check of the model. In fact, whenever we neglected 
τ1 and fitted only φ2, the RESNORM analysis demonstrated 
that a double exponential fit did not improve the quality of 
fitting (RESNORM of mono-exponential fitting less than 1% 
lower than with double exponential fitting whenever A1 = 0 
L  min−1).
Steady state means were calculated as the average val-
ues of the last min of rest and of the 5th min of exercise. 
Arterial-venous  O2 concentration difference  (CaO2–Cv
O2) was calculated at rest and at exercise steady state as 
the ratio between V̇O2 and CO (Adami et al. 2014; Ferretti 
et al. 2017).
Statistics
Data are given as mean and standard deviation (SD) of the 
values obtained for each parameter from the average super-
imposed files of each subject, to account for inter-individ-
ual variability. Difference between rest and exercise steady 
state was computed as the latter minus the former (Δ). The 
atropine-induced effects on the primary outcomes were ana-
lysed by a 2-way ANOVA (drug and X body position). When 
applicable, a Tukey post hoc test was used to locate signifi-
cant differences. The results were considered significant if 
p < 0.05. The parameters of the models were estimated with 
a weighted non-linear least squares procedure (Bringard 
et al. 2014; Carson et al. 1983), implemented in MATLAB 
(version 7.9.0,  MathWorks®, Natick, MA, USA).
Results
Resting and exercise steady‑state phase
The mean values of measured and calculated variables at 
rest and during exercise steady state for all conditions are 
reported in Table 1. HR in atropine, whether supine or 
upright, was higher than the control condition, both at rest 
(p < 0.05) and at exercise (p < 0.05). At rest in the supine 
position and during exercise in both postures, SV was 
lower under atropine than in control (p < 0.05). In upright 
posture, SV was always lower than in supine posture 
(p < 0.001), except in control during exercise (p = 0.41). 
Resting CO was higher in atropine than in control, whether 
supine or upright (p < 0.05). In atropine, CO was lower in 
the upright than in supine posture, both at rest and during 
exercise (p < 0.05). Oxygen uptake value did not change 
at rest (p > 0.18). During exercise under vagal blockade, V̇
O2 was lower in upright than in supine posture (p = 0.01). 
A similar non-significant trend occurred also in control 
(p > 0.99).
The values for  [La]b, pH, and partial pressure of  CO2 
 (PCO2) in capillary blood are reported in Table 2. We 
observed no differences between rest and exercise (respec-
tively, p = 0.67, 0.21 and 0.07) or between atropine and 
control (respectively, p = 0.12, 0.94 and 0.08) in any of the 
investigated conditions.
Figure 1 reports the difference (Δ) between the exer-
cise steady state and the resting value for the investigated 
parameters. This difference is indicative of the overall 
amplitude of response during the rest–exercise transition 
for each parameter. The ΔHR was smaller under atropine 
than in control, when exercise was performed in both 
supine and upright position (p < 0.05). This was not the 
Table 1  2  Mean values of 
measured and calculated 
variables at rest and during 
exercise steady state, in 
control condition and with 
atropineMean values of 
measured and calculated 
variables at rest and during 
exercise steady state, in control 
condition and with atropine
Mean values of measured and calculated variables at rest and during exercise steady state, in control condi-
tion and with atropine
HR heart rate, SV stroke volume, CO cardiac output, V̇O2 oxygen consumption, min−1 beat per minute
*p < 0.05 vs. supine position, within the same condition
# p < 0.05 vs. control, within the same posture
Control Atropine
Supine Upright Supine Upright
HR Rest min−1 61 ± 10 71 ± 8 105 ±  9# 109 ±  9#
Exercise min−1 110 ± 10 105 ± 10 139 ±  13# 129 ±  13#
SV Rest mL 97 ± 13 79 ± 13* 78 ±  10# 66 ± 9*
Exercise mL 120 ± 15 108 ± 9 103 ±  16# 83 ±  11#,*
CO Rest L  min−1 5.9 ± 0.9 5.6 ± 1.0 8.2 ± 0.6# 7.1 ± 0.6#,*
Exercise L  min−1 12.9 ± 1.8 11.2 ± 1.3 14.1 ± 2.3 10.6 ± 1.6*
V̇O2 Rest L  min
−1 0.44 ± 0.06 0.51 ± 0.09 0.49 ± 0.08 0.49 ± 0.08
Exercise L  min−1 1.59 ± 0.10 1.53 ± 0.25 1.67 ± 0.09 1.43 ± 0.13*
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case for SV (p = 0.85 and 0.06) and V̇O2 (p = 0.98 and 
0.58) therefore, ΔCO only tended to decrease in atropine 
with respect to control (p = 0.20 and 0.005).
Calculated  CaO2–CvO2 values are reported in Fig. 2. No 
differences were found among all four conditions whether 
at rest or at exercise steady state. As expected,  CaO2–CvO2 
was higher at exercise than at rest in all conditions (p < 0.05).
Kinetics responses
Individual examples of the time course of HR and CO kinet-
ics upon exercise onset are shown in Fig. 3.
In no case d1 differed from 0, so we retained no time 
delay for φ1. Parameters of the double exponential equa-
tion describing HR kinetics are shown in Fig. 4. In control, 
φ1 was visible in the whole cohort in upright and supine 
position, except for one subject in the latter body position. 
Under atropine, φ1 was identified only in five subjects in 
supine and in two subjects in upright position. The magni-
tude of A1 was smaller in atropine than in control (p < 0.001 
and 0.05). Similar results were found when A1 was expressed 
as a percentage of ΔHR (in the supine position, A1 was 
50 ± 21% in control and 11 ± 14% in atropine, p < 0.05; in the 
upright position, A1 was 70 ± 16% in control and 11 ± 22% in 
atropine, p < 0.05). A2 was smaller in upright position both 
in control (p < 0.05) and under vagal blockade (p < 0.001). 
Concerning τ1, the lack of values under atropine, especially 
in an upright posture (n = 2) makes a statistical comparison 
meaningless. In supine posture, τ2 was larger in atropine than 
in control (p < 0.05).
The parameters of the double exponential equation 
describing the CO kinetics at the exercise onset are shown 
in Fig. 5. For CO, A1 was lower in atropine than in control 
Table 2   Mean values of [La]b pH and PCO2 at rest and during exercise steady state, in control condition and with atropine
Mean values of [La]b pH and  PCO2 at rest and during exercise steady state, in control condition and with atropine
[La]b blood lactate concentration, pH hydrogen potential, PCO2 partial pressure of  CO2
Control Atropine
Supine Upright Supine Upright
[La]b Rest L  min−1 0.96 ± 0.12 0.63 ± 0.05 1.13 ± 0.12 0.71 ± 0.05
Exercise L  min−1 1.00 ± 0.09 0.68 ± 0.10 1.20 ± 0.01 0.68 ± 0.06
pH Rest 7.44 ± 0.00 7.44 ± 0.00 7.44 ± 0.00 7.44 ± 0.00
Exercise 7.43 ± 0.00 7.43 ± 0.00 7.43 ± 0.01 7.43 ± 0.00
PCO2 Rest mmHg 37.0 ± 0.6 36.1 ± 0.3 37.3 ± 0.5 38.0 ± 0.6
Exercise mmHg 38.7 ± 0.9 36.5 ± 0.4 38.9 ± 0.6 38.7 ± 0.3
Fig. 1  Difference (Δ) in heart rate, cardiac output, stroke volume and 
oxygen consumption between rest and exercise steady state in supine 
and upright position and for control situation and with atropine 
(n = 9). V̇O2 oxygen consumption, CO cardiac output, HR heart rate, 
SV stroke volume, *p < 0.05 vs. supine position; #p < 0.05 vs. control
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in the upright position (p < 0.05). No significant differ-
ence in τ1 was found, neither for body position (p = 0.98 
and 0.51) nor for atropine (p = 0.57 and 0.09). The values 
of A2 were the same in all conditions (p = 0.97 and 0.38). 
In atropine, τ2 was lower in the upright than supine posi-
tion (p < 0.001). In supine posture, τ2 was higher in atro-
pine than in control (p < 0.05). Notwithstanding, we also 
remark that the τ2 mean value in atropine was affected by 
an outlier value (τ2 of 101.4, at the limit of two SD above 
the group mean).
Double exponential analysis was applied to V̇O2 kinet-
ics in all subjects, in all experimental conditions. Param-
eters of the double exponential equation describing V̇O2 
kinetics at the exercise onset are shown in Fig. 6. In atro-
pine, A2 and τ2 were lower in the upright than in supine 
position (p < 0.05).
Discussion
This study provides the first demonstration of the effects 
of parasympathetic blockade on the cardiorespiratory 
response during exercise transients. Under atropine, φ1 
for HR was almost completely suppressed suggesting that 
the A1 for CO response kinetics was determined uniquely 
by the changes in SV. The lower values of A1 for CO found 
during exercise performed after atropine injection, com-
pared to the control condition, corresponds to the contri-
bution of HR to the φ1 in CO kinetics. These findings are 
in agreement with what we originally hypothesized and 
they represent the most current quantitative demonstration 
of the role of the inhibition of vagal modulation of HR at 
exercise start in determining the early CO response. The 
pattern followed by the different pertinent variables are 
analysed herewith, as an introduction to a holistic discus-
sion of φ1 kinetics.
Heart rate
The observation that under vagal blockade in both pos-
tures the A1 for HR was largely reduced, if not altogether 
suppressed, was not surprising. Fagraeus and Linnarsson 
(1976) were the first to analyse the rapid response of HR 
at exercise onset on a beat-by-beat basis. Although they 
did not model the transient kinetics, they observed that 
atropine remarkably slowed the overall HR response at 
exercise onset. Craig and Cummings (1963) reported what 
they called a “blocking effect” of atropine on the initial 
rapid HR increase, in a study in which HR was averaged 
over 10 s periods, thereby obtaining a dampened response. 
Later, using the supine knee extension model, Toska et al. 
(1994) confirmed that the initial rapid increase of HR at 
exercise onset was altered under atropine injection, thus 
demonstrating that the effect was independent of posture. 
Their results are in line with the present ones, as long as 
we found no differences concerning A1 for HR between the 
two investigated postures. Lador et al. (2006) were the first 
who applied a double exponential model to the analysis 
of the HR kinetics, by extending the application range of 
the model developed by Barstow and Molé (1987) for the 
study of V̇O2 kinetics. Based on the results of Fagraeus 
and Linnarsson (1976), Lador et al. (2006) postulated that 
the A1 for HR was the result of withdrawal of vagal tone at 
exercise start. The same group provided two further indi-
rect pieces of evidence supporting that conclusion. First, 
they found that the A1 for HR was smaller in acute hypoxia 
than in normoxia (Lador et al. 2008) since in hypoxia, rest-
ing modulation of HR by the vagal system is blunted with 
respect to normoxia (Xie et al. 2001), resting HR is higher 
Fig. 2  Calculated arterial-venous  O2 difference between rest and 
exercise steady state in supine and upright position and for control sit-
uation and with atropine. CaO2–CvO2 arterial-venous  O2 difference; 
*p < 0.05 vs. rest
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Fig. 3  Individual examples of the time course of heart rate and car-
diac output in supine and upright position and for control situation 
and with atropine. Single beat data (grey trace) and corresponding fit-
ting function (black line) are reported. A–D heart rate  (min−1); E–H: 
cardiac output (L  min−1). Conditions: A, E control supine; B, F con-
trol upright; C, G atropine supine; D, H atropine upright. All traces 
were fitted by the double exponential model (sum of two exponen-
tials). However, fitting of the traces reported in C (atropine supine, 
heart rate) and D (atropine upright, heart rate) yielded phase I ampli-
tude equal to zero: thus, they were fitted as monoexponential func-
tions, due to the absence of phase I, as detailed in the method section
 European Journal of Applied Physiology
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and A1 for HR is lower in the former than in the latter 
case. Second, if vagal withdrawal occurs, its occurrence 
is immediate at the exercise start (Bringard et al. 2017).
As expected (Nyberg 1981; Toska and Eriksen 1993; 
Wray et al. 2001), the resting HR of our study was higher 
in atropine than in control (Table 1), whereas the A1 was 
lower (Fig. 3). Therefore, the vagal modulation of the heart 
was already suppressed at rest, and no vagal withdrawal 
was possible at exercise onset. In control, the sum of rest-
ing HR (Table 1), and the A1 of HR provides the theoretical 
φ1 asymptote for HR. In control, this sum resulted 85 and 
94  min−1 supine and upright, respectively. This means that in 
φ1 the HR has increased by 24  min−1 supine and by 23  min−1 
upright above the respective resting values. Under atropine, 
Fig. 4  Heart rate kinetics between rest and exercise steady state in 
supine and upright position and for control situation and with atro-
pine. HR heart rate, A amplitude, τ time constant. The subscripts 
1 and 2 refer to the φ1 and the φ2 of the bi-exponential model; (n): 
number of subjects on which τ1 was computed; *p < 0.05 vs. supine 
position; #p < 0.05 vs. control
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the φ1 asymptote for HR was 109 and 111  min−1, supine and 
upright, respectively. The former value is identical to the 
resting HR supine, the latter was only 5  min−1 higher than 
the resting HR value upright.
In heart transplant recipients, the basal HR at rest is in 
the range 100–112   min−1 (Pflugfelder et al. 1987; Con-
vertino et al. 1990; Shephard 1992; Backman et al. 1997; 
Grassi et al. 1997; Strobel et al. 1999; Ferretti et al. 2002; 
Fig. 5  Cardiac output kinetics between rest and exercise steady state 
in supine and upright position and for control situation and with atro-
pine. CO cardiac output, A amplitude, τ time constant. The subscripts 
1 and 2 refer to the φ1 and the φ2 of the bi-exponential model; (n): 
number of subjects on which τ1 was computed. *p < 0.05 vs. supine 
position; #p < 0.05 vs. control
 European Journal of Applied Physiology
1 3
Kaufmann et al. 2007). In atropine, independently of the 
posture, the resting HR values are fully within this range, 
indicating complete suppression of cardiac vagal control 
by atropine. Coherently, the φ1 asymptote for HR under 
atropine remained practically equal to the resting HR. This 
is due to the extremely low A1 amplitude in atropine, as a 
result of a lack of vagal withdrawal at exercise start (the 
vagus is already inhibited at rest). Our hypothesis was that 
vagal withdrawal explains the HR increase in φ1 at exercise 
onset, and these findings confirmed our original assumption. 
Nevertheless, the φ1 asymptote for HR was higher under 
atropine than in control. If our hypothesis was correct, these 
data would suggest that in control, at the power used for this 
study, the withdrawal of vagal tone upon exercise start was 
Fig.6  Oxygen consumption kinetics at rest and exercise steady state 
in supine and upright position and for control situation and with atro-
pine. V̇O2 oxygen uptake, A amplitude, τ: time constant. The sub-
scripts 1 and 2 refer to the φ1 and the φ2 of the bi-exponential model; 
(n): number of subjects on which τ1 was computed. *p < 0.05 vs. 
supine position
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incomplete, as the HR at the asymptote of φ1 remains lower 
than that we would expect under parasympathetic blockade. 
The equal magnitude of A1 in supine and upright indicates 
that the HR response in φ1 is independent of body posture.
In φ2, the time constant was similar to that of previous 
studies (Lador et al. 2006, 2013). A2 is smaller in the upright 
than supine in control, a condition in which both branches 
of the autonomic nervous system are active. Under atropine, 
the resting HR is the same, yet the A2 is smaller upright 
than supine. This may mean that resting HR is mostly deter-
mined by the parasympathetic heart modulation, whereas the 
degree of sympathetic system stimulation during exercise 
determines the amplitude of the φ2 HR response. This inter-
pretation would be compatible with the hypothesis proposed 
by Lador et al. (2006) of a predominant sympathetic role in 
A2 for HR.
The sum of A1 plus A2 is the overall HR response to 
exercise and it should correspond to ΔHR. A comparison 
between these two parameters shows that this is the case 
indeed. In fact, the sum of A1 plus A2, expressed in  min−1, 
was 46 ± 5 in control supine, 34 ± 7 in control upright, 33 ± 4 
in atropine supine, 20 ± 6 in atropine upright. A compari-
son of these values with the ΔHR data reported in Fig. 1 
shows that the former corresponds well to the latter in each 
condition.
Cardiac output
Different patterns appear concerning CO responses. Con-
trary to HR, CO shows a positive φ1 response under atro-
pine and control experimental conditions. However, A1 is 
smaller in atropine than in control, because in atropine the 
φ1 response is entirely due to SV response, considering the 
A1 for HR negligible. In this condition, it is possible to dis-
tinguish the SV role from the HR role in determining the 
φ1 CO response. Both in supine and in upright posture, the 
CO response due to SV in control is equal to the A1 for CO 
in atropine; the fraction of the CO response due to HR in 
control is equal to the difference between the A1 for CO in 
control and the A1 for CO in atropine. Is this difference com-
patible with the φ1 increase for HR? This is hard to establish 
because SV is also a matter of telediastolic volume, which 
depends on the diastole duration, which is shorter in atropine 
than in control. Nevertheless, it is a matter of fact that these 
results show that atropine reduced A1 for CO but did not 
suppress it. It was reduced because of the suppression of A1 
for HR. Thus, the remaining yet lower CO response in φ1 
under atropine cannot be a consequence of vagal withdrawal, 
because there is no vagal withdrawal between rest and exer-
cise in this case: the parasympathetic system is inhibited all 
time long. It cannot be due to increased sympathetic stimu-
lation at exercise, because the φ1 duration is too short for 
that. If sympathetic stimulation plays a role, it would be 
responsible only for the φ2 CO response, both for its chrono-
tropic and inotropic effect on the heart.
These results confirm the hypothesis of the muscle pump 
mechanism, originally proposed by Sheriff et al. (1993) on 
animals and later resumed to explain the CO increase in 
heart transplant recipients (Meyer et al. 1998). This mecha-
nism, which was finally demonstrated also in healthy humans 
under Lower Body Negative Pressure (Fagoni et al. 2020), 
may well operate to determine the entire φ1 CO response 
when the vagal system is blocked and therefore there is no 
HR contribution to the φ1 CO kinetics.
Oxygen uptake
Concerning the V̇O2 kinetics, φ1 was visible in all conditions. 
There was no decrease of following atropine injection. Lador 
et al. (2006) showed, with the Fick principle, that the φ1 ampli-
tude of the CO kinetics explains entirely the φ1 amplitude of 
the V̇O2 kinetics, in line with the cardiodynamic hypothesis of 
Wasserman et al. (1974). Because of a delay between muscle 
 O2 consumption and lung  O2 uptake (DeLorey et al. 2003), we 
can assume that the composition of A1 mixed venous blood 
remains unchanged during the first seconds of exercise, and 
thus arterial-venous  O2 difference  (CaO2–CvO2) stays equal 
to that at rest. In fact this assumption is not in clear contrast 
with the kinetics of  CaO2–CvO2 that we could estimate after 
Casaburi et al (1989), who determined a kinetics of mixed 
venous oxygen saturation (SvO2) with a time resolution of 
4 s and characterised by a half-time of 32 s (time constant 
of approximately 46 s): within the time resolution of φ1 this 
would imply a negligible error indeed. Thus, if we assume 
that  CaO2–CvO2 stays equal to that at rest, and we accept the 
cardiodynamic hypothesis of Wasserman et al (1974), we can 
thus predict the change in A1 for V̇O2 by applying the Fick 
principle and multiplying A1 for CO and  CaO2–CvO2 at rest 
(Lador et al. 2006). The predicted A1 for V̇O2 is compared 
with the one that we determined in this study using the double 
exponential model in Table 3.
Table 3   Measured and recalculated V̇O2 kinetics increase at rest and 
during exercise steady state, in control condition and with atropine
Measured and recalculated V̇O2 kinetics increase at rest and during 
exercise steady state, in control condition and with atropine
V̇O2 oxygen uptake
*p < 0.01 vs. measured












Measured L  min−1 0.23 0.37 0.21 0.39
Recalcu-
lated
L  min−1 0.24 0.33 0.11* 0.11*
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The correspondence between recalculated and measured 
A1 values for V̇O2 is excellent in control, as was the case in 
Lador et al (2006). Conversely, in atropine, the calculated 
A1 was much less than the observed A1 for V̇O2 (p < 0.01 
both supine and upright). Several hypotheses have been for-
mulated to explain the CO-induced V̇O2 increase (De Cort 
et al. 1991; Yoshida et al. 1993; Leyk et al. 1995; Lador et al. 
2006). We highlight an intriguing speculative hypothesis, 
among these. In a previous study published by our group, 
the combined analysis of the HR and the mean arterial pres-
sure (MAP) responses, at the onset of exercise, has shown 
that the φ1 HR increase, which we attribute to vagal with-
drawal, corrects the immediate fall of MAP due to sudden 
muscle vasodilatation (Bringard et al. 2017). In that study, 
the increase in HR occurs along a baroreflex sequence, the 
sensitivity of which is equal to that observed not only at 
exercise steady state (Iellamo et al. 1994, 1997; Vallais 
et al. 2009), but also after vagal blockade (Fontolliet et al. 
2018). Vagal withdrawal is immediate, then HR follows with 
some inertia (positive τ1) along a baroreflex curve whose 
operational point is displaced from the centring point. We 
speculate that this baroreflex response may play a role in 
the coupling of the CO and the V̇O2 response. If this is cor-
rect, then in atropine there would not be the HR increase, 
but baroreceptor stimulation would persist, thus maintain-
ing an intact ventilatory response, which is not under vagal 
blockade, contrary to the heart. An analysis of the dynamics 
of baroreflex responses in the early phase of exercise should 
help in better focusing and analysing this issue: this should 
be the object of a further study.
If the baroreflexes are involved in coupling the CO and 
the V̇O2 response, the mechanism that determines V̇O2 A1: 
(1) is neural; (2) is generated outside the lungs and is likely 
to operate at the brain stem level (several hypotheses exist 
on this subject, see e.g. Lador et al. (2013); (3) has effects on 
the heart that are mediated by the vagal system; (4) generate 
an integrated response such that a stronger stimulus is sent 
to the lungs than to the heart; (5) is calibrated in such a way 
as to provide V̇O2 responses that are compatible, in terms of 
gas exchange, with the CO responses.
It goes without saying that the φ1 V̇O2 kinetics, especially 
if it has a “cardiodynamic” origin, is unrelated to events 
occurring within the muscles. In fact, the double exponen-
tial model, dissociates, at least as far as φ1 is concerned, 
from the muscle oxygen consumption kinetics, the control 
of which is metabolic (Ferretti 2015).
Steady‑state phase
Ekblom et al. (1972) and Fagraeus and Linnarsson (1976) 
reported that HR was higher at rest, but lower at exercise 
steady state in atropine compared to control. This result 
was confirmed later by Toska et al. (1994) and Fisher et al. 
(2013), the latter using glycopyrrolate to induce parasym-
pathetic blockade. Our results are in line with those of 
Kelbaek et al. (1991), who reported higher HR and CO, at 
rest in both upright and supine posture, with atropine than 
in control. Using a slightly lower intensity of exercise than 
ours, Kelbaek et al. (1991) reported higher HR and CO at 
exercise steady-state in an upright posture with atropine, 
contrary to the present study, where the higher HR was 
associated with unchanged CO under atropine compared to 
control. This discrepancy could arise from the difference 
in exercise intensity used between these studies or from 
the semi-recumbent posture used by those authors. Ekb-
lom et al. (1972) reported no alteration of CO neither at 
rest (contrary to the present study) nor during submaximal 
exercise, (in agreement with our study), under atropine, 
compared to control. Of note, the amount of atropine was 
lower in Ekblom et al (1972) study (2.0–2.5 mg), com-
pared to the current one.
Contrary to our findings, Ekblom et al. (1972) and Davies 
et al. (1976) did not observe the modification of steady-state 
V̇O2 during moderate exercise in upright posture, under atro-
pine. Using normobaric hypoxia, which has been postulated 
to reduce vagal activity and increase sympathetic activity 
at rest, Lador et al (2008) observed that rest and exercise 
steady-state values for HR and CO were increased, without 
any change for V̇O2.
Conclusions
In conclusion, atropine administration suppresses φ1 for HR 
almost completely, in agreement with the vagal withdrawal 
concept at exercise onset. Therefore, only SV changes deter-
mine A1 for CO response after atropine injection. The differ-
ences in A1 for CO between atropine and control highlight 
the contribution of HR to the A1 for CO. These results pro-
vide the first direct demonstration of the effects of inhibition 
of vagal modulation of HR at exercise onset on the φ1 CO 
kinetics.
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